OncoTherad® (MRB-CFI-1) nano-immunotherapy reduced tumoral progression in non-muscle invasive bladder cancer through activation of Toll-like signaling pathway
Author:
Funder
FAPESP
CAPES
CNPq
Publisher
Elsevier BV
Subject
Cell Biology,Developmental Biology,General Medicine
Reference51 articles.
1. Oncotherad immunotherapy elicits promising responses in Bacillus Calmette-Guérin-unresponsive non–muscle invasive bladder cancer: results from phase I/II study;Alonso;J. Clin. Oncol.,2020
2. IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: the significance of modulating such cytokines in treating malignant solid tumors;Alshaker;Cancer Cell Int.,2011
3. Overview: Bladder Cancer. in: What Are the Key Statistics About Bladder Cancer? American Cancer society, Atlanta;American Cancer Society,2021
4. Bladder cancer incidence and mortality: a global overview and recent trends;Antoni;Eur. Urol.,2017
5. Bladder Cancer immunotherapy: BCG and beyond;Askeland;Adv. Urol.,2012
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Preparation and properties of chitosan/dialdehyde sodium alginate/dopamine magnetic drug-delivery hydrogels;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-01
2. Recent advances in platelet-rich plasma and its derivatives: therapeutic agents for tissue engineering and regenerative medicine;Progress in Biomedical Engineering;2024-01-01
3. OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette–Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway;International Journal of Molecular Sciences;2023-12-15
4. A novel therapeutic strategy for non-muscle invasive bladder cancer: OncoTherad® immunotherapy associated with platelet-rich plasma;International Immunopharmacology;2023-10
5. Evaluation of the tissue repair process and immunomodulatory action of Platelet-Rich Plasma (PRP) in the treatment of abdominal stretch marks;Tissue and Cell;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3